Benzinga  Apr 1  Comment 
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has initiated market launch and made its first shipments of the authorized generic version of LEO Pharma A/S' Taclonex® Ointment (calcipotriene 0.005% / betamethasone dipropionate...
StreetInsider.com  Mar 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+Enters+Agreement+to+Produce+Knock-Off+Ensure/9318117.html for the full story.
SeekingAlpha  Mar 24  Comment 
By Len Zehr: Transition Therapeutics (TTHI) has added late-stage drug development to its operations with its acquisition from Perrigo plc (PRGO) of neuropsychiatric drug candidate, ELND005. "We're maybe a year away from seeing the results of...
Benzinga  Mar 3  Comment 
In a report published Monday, Morgan Stanley analyst David Risinger reiterated an Overweight rating on Perrigo Company (NYSE: PRGO), but removed the $167.00 price target. In the report, Morgan Stanley noted, “Double-digit EPS growth looks...
StreetInsider.com  Feb 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+Announces+Transfer+of+ELND005+to+Transition+Therapeutics+%28TTHI%29/9229458.html for the full story.
SeekingAlpha  Feb 6  Comment 
Perrigo (PRGO) Q2 2014 Earnings Call February 06, 2014 10:00 am ET Executives Arthur J. Shannon - Vice President of Investor Relations & Global Communication Joseph C. Papa - Chairman, Chief Executive Officer and President Judy L....
StreetInsider.com  Feb 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Perrigo+%28PRGO%29+Sees+FY14+YE+Revs+Growth+at+15%25+-+18%25%3B+Est.+at+18%25/9133991.html for the full story.
Wall Street Journal  Feb 6  Comment 
Perrigo swung to a fiscal second-quarter loss on acquisition expenses, but the store-brand pharmaceutical and nutritional-products maker's revenue continued to grow on strength in its pharmaceutical business.
StreetInsider.com  Feb 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Perrigo+Co+%28PRGO%29+Tops+Q2+EPS+by+28c%3B+Boosts+FY14+Profit+Outlook/9132941.html for the full story.
StreetInsider.com  Jan 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Dividends/Perrigo+Company+plc+%28PRGO%29+Declares+%240.105+Quarterly+Dividend%3B+0.3%25+Yield/9100631.html for the full story.


Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki